Angiodysplasia secondary prevention: Difference between revisions
Nikita Singh (talk | contribs) |
Nikita Singh (talk | contribs) |
||
| Line 8: | Line 8: | ||
[[Secondary prevention]] aims to detect a disease earlier to allow timely intervention to reduce the impacts of the disease after it has already occurred. | [[Secondary prevention]] aims to detect a disease earlier to allow timely intervention to reduce the impacts of the disease after it has already occurred. | ||
For angiodysplasia, the role of vasoactive drugs in the prevention of acute bleeding events and beta blockers to reduce the mesenteric blood flow for secondary prophylaxis is still equivocal. | For angiodysplasia, the role of vasoactive drugs in the prevention of acute bleeding events and beta blockers to reduce the mesenteric blood flow for secondary prophylaxis is still equivocal.<ref name="pmid1575371">{{cite journal| author=Schwartz J, Rozenfeld V, Habot B| title=Cessation of recurrent bleeding from gastrointestinal angiodysplasia, after beta blocker treatment in a patient with hypertrophic subaortic stenosis--a case history. | journal=Angiology | year= 1992 | volume= 43 | issue= 3 Pt 1 | pages= 244-8 | pmid=1575371 | doi=10.1177/000331979204300309 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1575371 }} </ref> | ||
==References== | ==References== | ||
Revision as of 07:28, 15 October 2021
|
Angiodysplasia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Angiodysplasia secondary prevention On the Web |
|
American Roentgen Ray Society Images of Angiodysplasia secondary prevention |
|
Risk calculators and risk factors for Angiodysplasia secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nikita Singh, M.D.[2]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Secondary Prevention
Secondary prevention aims to detect a disease earlier to allow timely intervention to reduce the impacts of the disease after it has already occurred.
For angiodysplasia, the role of vasoactive drugs in the prevention of acute bleeding events and beta blockers to reduce the mesenteric blood flow for secondary prophylaxis is still equivocal.[1]
References
- ↑ Schwartz J, Rozenfeld V, Habot B (1992). "Cessation of recurrent bleeding from gastrointestinal angiodysplasia, after beta blocker treatment in a patient with hypertrophic subaortic stenosis--a case history". Angiology. 43 (3 Pt 1): 244–8. doi:10.1177/000331979204300309. PMID 1575371.